Peptide nanofibrils as enhancers of retroviral gene transfer

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 6, Issue 5, 2014, Pages 438-451

  Meier, Christoph ^a   Weil, Tanja ^a   Kirchhoff, Frank ^b   Münch, Jan ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BODY FLUIDS; DRUG DELIVERY; GLYCOPROTEINS; NANOFIBERS; NEURODEGENERATIVE DISEASES; PEPTIDES; STOCHASTIC SYSTEMS; VIRUSES;

ALZHEIMER'S DISEASE; BIOLOGICAL FUNCTIONS; CONFLICT OF INTEREST; CONVENTIONAL ADDITIVES; NEURODEGENERATIVE DISORDERS; RETROVIRAL GENE TRANSFERS; SELF-ASSEMBLING PEPTIDES; TRANSMISSION RATES;

GENE TRANSFER;

AMYLOID; FIBRIN MONOMER; NANOFIBER; PEPTIDE; POLYPEPTIDE; RETROVIRUS VECTOR;

ALZHEIMER DISEASE; BIOSYNTHESIS; CENTRIFUGATION; DISEASE ACTIVITY; ENHANCER REGION; EX VIVO STUDY; FIBER; GENE TRANSFER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW; SEMEN DERIVED ENHANCER OF VIRUS INFECTION; SEXUAL TRANSMISSION; SPERM; STANDARD; STOCHASTIC MODEL; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; ANIMAL; CHEMISTRY; GENETIC TRANSDUCTION; HEK293 CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS 1; VIRUS GENE;

AMYLOID; ANIMALS; GENES, VIRAL; HEK293 CELLS; HIV INFECTIONS; HIV-1; HUMANS; NANOFIBERS; PEPTIDES; SEMEN; TRANSDUCTION, GENETIC;

EID: 84905034845     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1275     Document Type: Review

References (72)

1. Heemskerk B, Jorritsma A, Gomez-Eerland R, Toebes M, Haanen JBAG, Schumacher TNM. Microbead-assisted retroviral transduction for clinical application. Hum Gene Ther 2010, 21:1335-1342. doi: 10.1089/hum.2009.208.
2. Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C, Sergi Sergi L, Benedicenti F, Ambrosi A, Di Serio C, et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 2006, 24:687-696. doi: 10.1038/nbt1216.
3. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267.
4. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997, 15:871-875. doi: 10.1038/nbt0997-871.
5. Coffin JM, Hughes SH, Varmus HE. Retroviruses (The Interactions of Retroviruses and their Hosts). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1997.
6. Zhang X, Godbey WT. Viral vectors for gene delivery in tissue engineering. Adv Drug Deliv Rev 2006, 58:515-534. doi: 10.1016/j.addr.2006.03.006.
7. Barquinero J, Eixarch H, Pérez-Melgosa M. Retroviral vectors: new applications for an old tool. Gene Ther 2004, 11:S3-S9. doi: 10.1038/sj.gt.3302363.
8. Schambach A, Zychlinski D, Ehrnstroem B, Baum C. Biosafety features of lentiviral vectors. Hum Gene Ther 2013, 24:132-142. doi: 10.1089/hum.2012.229.
9. Segura MM, Mangion M, Gaillet B, Garnier A. New developments in lentiviral vector design, production and purification. Expert Opin Biol Ther 2013, 13:987-1011. doi: 10.1517/14712598.2013.779249.
10. Perkins AS, Kirschmeier PT, Gattoni-Celli S, Weinstein IB. Design of a retrovirus-derived vector for expression and transduction of exogenous genes in mammalian cells. Mol Cell Biol 1983, 3:1123-1132.
11. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal-Cortivo L, Caccavelli L, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009, 326:818-823. doi: 10.1126/science.1171242.
12. Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, Baldoli C, Martino S, Calabria A, Canale S, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 2013, 341:1233158. doi: 10.1126/science.1233158.
13. Coroadinha ASA, Gama-Norton LL, Amaral AIA, Hauser HH, Alves PMP, Cruz PEP. Production of retroviral vectors: a review. Curr Gene Ther 2010, 10:456-473.
14. Davis HE, Morgan JR, Yarmush ML. Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem 2002, 97:159-172.
15. Toyoshima K, Vogt PK. Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 1969, 38:414-426. doi: 10.1016/0042-6822(69)90154-8.
16. Leydet A, Moullet C, Roque JP, Witvrouw M, Pannecouque C, Andrei G, Snoeck R, Neyts J, Schols D, De Clercq E. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission. J Med Chem 1998, 41:4927-4932. doi: 10.1021/jm970661f.
17. Leydet A, Barragan V, Boyer B, Montéro JL, Roque JP, Witvrouw M, Este J, Snoeck R, Andrei G, De Clercq E. Polyanion inhibitors of human immunodeficiency virus and other viruses. 5. Telomerized anionic surfactants derived from amino acids. J Med Chem 1997, 40:342-349. doi: 10.1021/jm960493b.
18. Leydet A, Jeantet-Segonds C, Bouchitté C, Moullet C, Boyer B, Roque JP, Witvrouw M, Este J, Snoeck R, Andrei G, et al. Polyanion inhibitors of human immunodeficiency virus and other viruses. 6. Micelle-like anti-HIV polyanionic compounds based on a carbohydrate core. J Med Chem 1997, 40:350-356. doi: 10.1021/jm960348y.
19. Leydet A, El Hachemi H, Boyer B, Lamaty G, Roque JP, Schols D, Snoeck R, Andrei G, Ikeda S, Neyts J, et al. Polyanion inhibitors of human immunodeficiency virus and other viruses. Part 2. Polymerized anionic surfactants derived from amino acids and dipeptides. J Med Chem 1996, 39:1626-1634. doi: 10.1021/jm950358j.
20. Leydet A, Barthelemy P, Boyer B, Lamaty G, Roque JP, Bousseau A, Evers M, Hénin Y, Snoeck R, Andrei G. Polyanion inhibitors of human immunodeficiency virus and other viruses. 1. Polymerized anionic surfactants. J Med Chem 1995, 38:2433-2440.
21. Cornetta KK, Anderson WFW. Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. J Virol Methods 1989, 23:187-194.
22. Davis HE, Rosinski M, Morgan JR, Yarmush ML. Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J 2004, 86:1234-1242. doi: 10.1016/S0006-3495(04)74197-1.
23. Lin P, Correa D, Lin Y, Caplan AI. Polybrene inhibits human mesenchymal stem cell proliferation during lentiviral transduction. PLoS One 2010, 6:e23891. doi: 10.1371/journal.pone.0023891.
24. Hodgson CP, Solaiman F. Virosomes: cationic liposomes enhance retroviral transduction. Nat Biotechnol 1996, 14:339-342. doi: 10.1038/nbt0396-339.
25. Vogt PK. DEAE-dextran: enhancement of cellular transformation induced by avian sarcoma viruses. Virology 1967, 33:175-177.
26. Kimizuka F, Taguchi Y, Ohdate Y, Kawase Y, Shimojo T, Hashino K, Kato I, Sekiguchi K, Titani K. Production and characterization of functional domains of human fibronectin expressed in Escherichia coli. J Biol Chem 1991, 110:284-291.
27. http://www.takara-bio.com/medi_e/retro.html. (Accessed January 20, 2014).
28. Innes CL, Smith PB, Langenbach R, Tindall KR, Boone LR. Cationic liposomes (Lipofectin) mediate retroviral infection in the absence of specific receptors. J Virol 1990, 64:957-961.
29. Konopka K, Davis BR, Larsen CE, Alford DR, Debs RJ, Düzgüneş N. Liposomes modulate human immunodeficiency virus infectivity. J Gen Virol 1990, 71:2899-2907.
30. Faller DV, Baltimore D. Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines. J Virol 1984, 49:269.
31. Ghatak P, Karmakar K, Kasetty S, Chatterji D. Unveiling the role of Dps in the organization of mycobacterial nucleoid. PLoS One 2011, 6:e16019. doi: 10.1371/journal.pone.0016019.
32. Bromfield SM, Wilde E, Smith DK. Heparin sensing and binding - taking supramolecular chemistry towards clinical applications. Chem Soc Rev 2013, 42:9184-9195. doi: 10.1039/C3CS60278H.
33. Fenard D, Ingrao D, Seye A, Buisset J, Genries S, Martin S, Kichler A, Galy A. Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells. Mol Ther Nucleic Acids 2013, 2:e90. doi: 10.1038/mtna.2013.17.
34. Arnold F, Schnell J, Zirafi O, Stürzel C, Meier C, Weil T, Ständker L, Forssmann W-G, Roan NR, Greene WC, et al. Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. J Virol 2012, 86:1244-1249. doi: 10.1128/JVI.06121-11.
35. Münch J, Rücker E, Ständker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007, 131:1059-1071. doi: 10.1016/j.cell.2007.10.014.
36. Roan NR, Müller JA, Liu H, Chu S, Arnold F, Stürzel CM, Walther P, Dong M, Witkowska HE, Kirchhoff F, et al. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe 2011, 10:541-550. doi: 10.1016/j.chom.2011.10.010.
37. Zhang L, Jiang C, Zhang H, Gong X, Yang L, Miao L, Shi Y, Zhang Y, Kong W, Zhang C, et al. A novel modified peptide derived from membrane-proximal external region of human immunodeficiency virus type 1 envelope significantly enhances retrovirus infection. J Pept Sci 2014, 20:46-54. doi: 10.1002/psc.2587.
38. Yolamanova M, Meier C, Shaytan AK, Vas V, Bertoncini CW, Arnold F, Zirafi O, Usmani SM, Müller JA, Sauter D, et al. Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses. Nat Nanotechnol 2013, 8:130-136. doi: 10.1038/nnano.2012.248.
39. Hanenberg H, Hashino K, Konishi H, Hock RA, Kato I, Williams DA. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum Gene Ther 1997, 8:2193-2206. doi: 10.1089/hum.1997.8.18-2193.
40. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996, 2:876-882.
41. Moritz T, Dutt P, Xiao X, Carstanjen D, Vik T, Hanenberg H, Williams DA. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 1996, 88:855-862.
42. Moritz T, Patel VP, Williams DA. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 1994, 93:1451-1457. doi: 10.1172/JCI117122.
43. Pollok KE, Williams DA. Facilitation of retrovirus-mediated gene transfer into hematopoietic stem and progenitor cells and peripheral blood T-lymphocytes utilizing recombinant fibronectin fragments. Curr Opin Mol Ther 1999, 1:595-604.
44. Pollok KE, Hanenberg H, Noblitt TW, Schroeder WL, Kato I, Emanuel D, Williams DA. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J Virol 1998, 72:4882-4892.
45. Quintás-Cardama A, Yeh RK, Hollyman D, Stefanski J, Taylor C, Nikhamin Y, Imperato G, Sadelain M, Rivière I, Brentjens RJ. Multifactorial optimization of γretroviral gene transfer into human T lymphocytes for clinical application. Hum Gene Ther 2007, 18:1253-1260. doi: 10.1089/hum.2007.088.
46. Zhou P, Lee J, Moore P, Brasky KM. High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T cell homing receptor expression. Hum Gene Ther 2001, 12:1843-1855. doi: 10.1089/104303401753153901.
47. Bechinger B, Vidovic V, Bertani P, Kichler A. A new family of peptide-nucleic acid nanostructures with potent transfection activities. J Pept Sci 2011, 17:88-93. doi: 10.1002/psc.1318.
48. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006, 75:333-366. doi: 10.1146/annurev.biochem.75.101304.123901.
49. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson KPR, Simon R, Schubert D, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 2009, 325:328-332. doi: 10.1126/science.1173155.
50. Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid-from bacteria to humans. Trends Biochem Sci 2007, 32:217-224. doi: 10.1016/j.tibs.2007.03.003.
51. Smith JF, Knowles TPJ, Dobson CM, MacPhee CE, Welland ME. Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci U S A 2006, 103:15806-15811. doi: 10.1073/pnas.0604035103.
52. Malisauskas M, Weise C, Yanamandra K, Wolf-Watz M, Morozova-Roche L. Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties. J Mol Biol 2010, 396:60-74. doi: 10.1016/j.jmb.2009.11.012.
53. Biancalana M, Makabe K, Koide A, Koide S. Molecular mechanism of thioflavin-T binding to the surface of β-rich peptide self-assemblies. J Mol Biol 2009, 385:1052-1063. doi: 10.1016/j.jmb.2008.11.006.
54. Elghetany MT, Saleem A. Methods for staining amyloid in tissues: a review. Biotech Histochem 1988, 63:201-212. doi: 10.3109/10520298809107185.
55. Makin OS, Serpell LC. Structures for amyloid fibrils. FEBS J 2005, 272:5950-5961. doi: 10.1111/j.1742-4658.2005.05025.x.
56. Kim K-A, Yolamanova M, Zirafi O, Roan NR, Staendker L, Forssmann W-G, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, et al. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 2010, 7:55. doi: 10.1186/1742-4690-7-55.
57. Münch J, Sauermann U, Yolamanova M, Raue K, Stahl-Hennig C, Kirchhoff F. Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus. Retrovirology 2013, 10:148. doi: 10.1186/1742-4690-10-148.
58. Castellano LM, Shorter J. The surprising role of amyloid fibrils in HIV infection. Biology 2012, 1:58-80.
59. Capule CC, Brown C, Olsen JS, Dewhurst S, Yang J. Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection. J Am Chem Soc 2012, 134:905-908. doi: 10.1021/ja210931b.
60. Olsen JS, Brown C, Capule CC, Rubinshtein M, Doran TM, Srivastava RK, Feng C, Nilsson BL, Yang J, Dewhurst S. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection. J Biol Chem 2010, 285:35488-35496. doi: 10.1074/jbc.M110.163659.
61. Roan NR, Sowinski S, Münch J, Kirchhoff F, Greene WC. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J Biol Chem 2010, 285:1861-1869. doi: 10.1074/jbc.M109.066167.
62. Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proc Natl Acad Sci U S A 2009, 106:9033-9038. doi: 10.1073/pnas.0811827106.
63. Roan NR, Münch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J Virol 2009, 83:73-80. doi: 10.1128/JVI.01366-08.
64. Wurm M, Schambach A, Lindemann D, Hanenberg H, Ständker L, Forssmann W-G, Blasczyk R, Horn PA. The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J Gene Med 2010, 12:137-146. doi: 10.1002/jgm.1429.
65. Wurm M, Gross B, Sgodda M, Ständker L, Müller T, Forssmann W-G, Horn PA, Blasczyk R, Cantz T. Improved lentiviral gene transfer into human embryonic stem cells grown in co-culture with murine feeder and stroma cells. Biol Chem 2011, 392:887-895. doi: 10.1515/BC.2011.085.
66. Leyva FJ, Anzinger JJ, McCoy JP, Kruth HS. Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectors. BMC Biotechnol 2011, 11:13. doi: 10.1186/1472-6750-11-13.
67. Hauser CAE, Zhang S. Designer self-assembling peptide nanofiber biological materials. Chem Soc Rev 2010, 39:2780-2790. doi: 10.1039/b921448h.
68. Dong H, Paramonov SE, Aulisa L, Bakota EL, Hartgerink JD. Self-assembly of multidomain peptides: balancing molecular frustration controls conformation and nanostructure. J Am Chem Soc 2007, 129:12468-12472. doi: 10.1021/ja072536r.
69. Castelletto V, Hamley IW, Cenker C, Olsson U. Influence of salt on the self-assembly of two model amyloid heptapeptides. J Phys Chem B 2010, 114:8002-8008. doi: 10.1021/jp102744g.
70. Bhattacharya M, Jain N, Mukhopadhyay S. Insights into the mechanism of aggregation and fibril formation from bovine serum albumin. J Phys Chem B 2011, 115:4195-4205. doi: 10.1021/jp111528c.
71. Easterhoff D, DiMaio JTM, Doran TM, Dewhurst S, Nilsson BL. Enhancement of HIV-1 infectivity by simple, self-assembling modular peptides. Biophys J 2011, 100:1325-1334. doi: 10.1016/j.bpj.2011.01.037.
72. Hartman K, Brender JR, Monde K, Ono A, Evans ML, Popovych N, Chapman MR, Ramamoorthy A. Bacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: cross-seeding of dissimilar amyloid sequences. PeerJ 2012, 1:e5. doi: 10.7717/peerj.5.